HIPAY GROUP SA (ALHYP.PA) Fundamental Analysis & Valuation

EPA:ALHYP • FR0012821916

Current stock price

5.84 EUR
-0.26 (-4.26%)
Last:

This ALHYP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHYP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALHYP was profitable.
  • In the past year ALHYP had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALHYP reported negative net income in multiple years.
  • Each year in the past 5 years ALHYP had a positive operating cash flow.
ALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

  • ALHYP's Return On Assets of 2.61% is in line compared to the rest of the industry. ALHYP outperforms 57.69% of its industry peers.
  • With a decent Return On Equity value of 13.62%, ALHYP is doing good in the industry, outperforming 71.15% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 5.74%, ALHYP is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROIC 5.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHYP.PA Yearly ROA, ROE, ROICALHYP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • ALHYP has a Profit Margin (7.88%) which is in line with its industry peers.
  • With a Operating Margin value of 6.71%, ALHYP perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
  • ALHYP's Gross Margin of 49.04% is in line compared to the rest of the industry. ALHYP outperforms 55.77% of its industry peers.
  • In the last couple of years the Gross Margin of ALHYP has grown nicely.
Industry RankSector Rank
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
ALHYP.PA Yearly Profit, Operating, Gross MarginsALHYP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALHYP.PA Health Analysis

2.1 Basic Checks

  • ALHYP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ALHYP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALHYP.PA Yearly Shares OutstandingALHYP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALHYP.PA Yearly Total Debt VS Total AssetsALHYP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 0.36, we must say that ALHYP is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ALHYP (0.36) is worse than 67.31% of its industry peers.
  • A Debt/Equity ratio of 0.41 indicates that ALHYP is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.41, ALHYP perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.55
WACC10.52%
ALHYP.PA Yearly LT Debt VS Equity VS FCFALHYP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • ALHYP has a Current Ratio of 1.05. This is a normal value and indicates that ALHYP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHYP has a Current ratio of 1.05. This is comparable to the rest of the industry: ALHYP outperforms 42.31% of its industry peers.
  • ALHYP has a Quick Ratio of 1.05. This is a normal value and indicates that ALHYP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHYP has a Quick ratio of 1.05. This is comparable to the rest of the industry: ALHYP outperforms 44.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ALHYP.PA Yearly Current Assets VS Current LiabilitesALHYP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALHYP.PA Growth Analysis

3.1 Past

  • ALHYP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.21%.
  • The Revenue has been growing slightly by 0.65% in the past year.
  • Measured over the past years, ALHYP shows a quite strong growth in Revenue. The Revenue has been growing by 10.34% on average per year.
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%

3.2 Future

  • ALHYP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
  • ALHYP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHYP.PA Yearly Revenue VS EstimatesALHYP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALHYP.PA Yearly EPS VS EstimatesALHYP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ALHYP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.28, the valuation of ALHYP can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALHYP indicates a rather cheap valuation: ALHYP is cheaper than 90.38% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.15, ALHYP is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 13.19, ALHYP is valued correctly.
  • ALHYP's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.12. ALHYP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 6.28
Fwd PE 13.19
ALHYP.PA Price Earnings VS Forward Price EarningsALHYP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALHYP is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.92
ALHYP.PA Per share dataALHYP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALHYP's earnings are expected to grow with 15.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALHYP.PA Dividend Analysis

5.1 Amount

  • No dividends for ALHYP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHYP.PA Fundamentals: All Metrics, Ratios and Statistics

HIPAY GROUP SA

EPA:ALHYP (4/27/2026, 7:00:00 PM)

5.84

-0.26 (-4.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)04-08
Earnings (Next)05-13
Inst Owners0.45%
Inst Owner ChangeN/A
Ins Owners50.11%
Ins Owner ChangeN/A
Market Cap36.85M
Revenue(TTM)74.78M
Net Income(TTM)5.89M
Analysts84.44
Price Target17.34 (196.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-35.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.47%
Valuation
Industry RankSector Rank
PE 6.28
Fwd PE 13.19
P/S 0.49
P/FCF N/A
P/OCF 5.93
P/B 0.85
P/tB N/A
EV/EBITDA 5.92
EPS(TTM)0.93
EY15.92%
EPS(NY)0.44
Fwd EY7.58%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.98
OCFY16.86%
SpS11.85
BVpS6.86
TBVpS-0.98
PEG (NY)0.61
PEG (5Y)N/A
Graham Number11.9781 (105.1%)
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROCE 7.81%
ROIC 5.74%
ROICexc 7.65%
ROICexgc N/A
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 2.02
Cap/Depr 169.65%
Cap/Sales 8.69%
Interest Coverage 1.58
Cash Conversion 70.2%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.36
F-Score4
WACC10.52%
ROIC/WACC0.55
Cap/Depr(3y)102.56%
Cap/Depr(5y)111.15%
Cap/Sales(3y)6%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.88%
OCF growth 3Y52.41%
OCF growth 5YN/A

HIPAY GROUP SA / ALHYP.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIPAY GROUP SA (ALHYP.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHYP.PA.


What is the valuation status for ALHYP stock?

ChartMill assigns a valuation rating of 5 / 10 to HIPAY GROUP SA (ALHYP.PA). This can be considered as Fairly Valued.


How profitable is HIPAY GROUP SA (ALHYP.PA) stock?

HIPAY GROUP SA (ALHYP.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for ALHYP stock?

The financial health rating of HIPAY GROUP SA (ALHYP.PA) is 3 / 10.